Posts Tagged ‘ Bristol-Myers Squibb Company ’

Cancer Vaccine Therapies: Failures and Future Opportunities

2
April 7, 2010
Cancer Vaccine Therapies: Failures and Future Opportunities

(Note: the following text is an Executive Summary from our new 150-page report titled “Cancer Vaccine Therapies: Failures and Future Opportunities”) Since the early 1990s, cancer immunotherapy has provided hope to patients, physicians, and investors as a new treatment modality with limited side effects and superior efficacy.  Cancer immunotherapy broadly includes passive immunization, active...
Read More »

Biotech Deal Activity Declines…The Pause that Refreshes?

1
January 14, 2010
Biotech Deal Activity Declines…The Pause that Refreshes?

* MD Becker Partners reporting live from the JP Morgan Healthcare Conference This week, nearly 6,500 registrants gathered in San Francisco, California for the JP Morgan Healthcare Conference to hear 25-minute presentations from 338 life science companies.  For industry executives and investors, the annual event serves as a good barometer for the rest of...
Read More »